The National Medical Products Administration (NMPA) has announced the release of the 82nd batch of reference drugs for its Generic Quality Consistency Evaluation (GQCE) program. This latest batch includes 25 new specifications and modifications to 8 existing ones, featuring a drug with a newly changed generic name, enarodustat, along with the addition of new Marketing Authorization Holders (MAHs). -Fineline Info & Tech
Recent news:
-
Hanx Biopharmaceuticals Files for IPO on Hong Kong Stock Exchange -
MSD Partners with Cancer Foundation of China for HPV Vaccine Donation Program -
Sciwind Biosciences' Ecnoglutide Accepted for Review by China's NMPA for Type 2 Diabetes -
Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation -
Leman Biotech Enters Zhongshan Life Science Park to Accelerate CAR-T Innovation
